TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Parthenolide, Temozolomide
Phytochemical Name Parthenolide (PubChem CID: 7251185 )
Anticancer drug Name Temozolomide (PubChem CID: 5394 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Reversing Drug Resistance
Hide/Show
Combination Pair ID: 176
Pair Name Parthenolide, Temozolomide
Disease Info [ICD-11: 2F7Z] Glioma Investigative
Gene Regulation Up-regulation Expression BAX hsa581
Down-regulation Expression BCL2 hsa596
Down-regulation Expression MGMT hsa4255
Down-regulation Activity NFKB1 hsa4790
Up-regulation Cleavage PARP1 hsa142
In Vitro Model T98G Glioblastoma Homo sapiens (Human) CVCL_0556
LN-18 Glioblastoma Homo sapiens (Human) CVCL_0392
Result These findings suggest that NF-κB is a potential target for inducing cell death in gliomas. A targeted combination strategy in which the response to TMZ is synergistically enhanced by the addition of parthenolide which may be useful, especially in chemoresistant gliomas with high MGMT expression.
03. Reference
No. Title Href
1 Inhibition of NF-κB results in anti-glioma activity and reduces temozolomide-induced chemoresistance by down-regulating MGMT gene expression. Cancer Lett. 2018 Aug 1;428:77-89. doi: 10.1016/j.canlet.2018.04.033. Click
It has been 26966 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP